The Asian indemnifier added China risk factors to its U.S. prospectus even though it doesn’t operate there. It feels like a last-ditch attempt to secure SEC approval before any buzz dies down. The Hong Kong bourse, which probably should have been Plan A, makes a suitable Plan B.